A comparison of perinatal HIV prevention opportunities for hispanic and non-hispanic women in California

AIDS Education and Prevention

Volumn 18, Issue 5, 2006, Pages 430-443

  Kropp, Rhonda Y ^a   Sarnquist, Clea C ^b   Montgomery, Elizabeth T ^b   Ruiz, Juan D ^c   Maldonado, Yvonne A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Office of AIDS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD CARE; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PERINATAL INFECTION; PRENATAL CARE; TRAFFIC AND TRANSPORT; UNITED STATES; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CALIFORNIA; COUNSELING; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES; HEALTH SURVEYS; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PERINATAL CARE;

EID: 33750631693     PISSN: 08999546     EISSN: 08999546     Source Type: Journal    
DOI: 10.1521/aeap.2006.18.5.430     Document Type: Article

References (37)

1. American Academy of Pediatrics/American College and Obstetricians and Gynecologists. (1992). Guidelines for Perinatal Care (3rd ed.). Washington, DC.
2. Barbacci, M., Repke, J.T., & Chaisson, R. (1991). Routine prenatal screening for HIV infection. Lancet, 337, 709-711.
3. California Department of Health Services, Center for Health Statistics. (2004). California HIV case surveillance report, cases reported through October 31, 2004 . Retrieved November 22, 2004, from www.dhs.ca.gov/
4. California Department of Health Services, Office of AIDS. (2000). An epidemiologic profile of women and children with HIV/AIDS in California. Retrieved September 25, 2001, from http://www.dhs.ca.gov/AIDS/ooaindex.htm.
5. California Department of Health Services. (1998). California Vital Records, Birth certificate public access file.
6. California Department of Health Services. (2002). California Vital Records, Birth certificate public access file.
7. California Senate Bill No. 1676 (2003). Human Immunodeficiency Virus: Maternal and Newborn Health. Health and Safety Code Secions 125085, 125090, 125107, 125092.
8. California Senate Bill No. 889 (1996). Chapter 873 California Prenatal HIV Testing Legislation. Retrieved September 4, 2001, from http://hivinsite. ucsf.edu/InSite.jsp?doc=2098.4161
9. Centers for Disease Control and Prevention (2004). Assessment of increase in perinatal exposure to HIV among Hispanics - 20 Counties, Georgia, 1994-2002. Morbidity and Mortality Weekly, 48(19), 401-404.
10. Centers for Disease Control and Prevention. (1999). Prenatal Discussion of HIV testing and Maternal HIV testing - 14 States, 1996-1997. Morbidity and Mortality Weekly Morb Mortal Wkly Report, 53(40), 944-946.
11. Centers for Disease Control and Prevention. (2001). Revised guidelines for HIV counseling, testing and referral and revised recommendations for HIV screening of pregnant women. Morbidity and Mortality Weekly, 50(RR-19), 1-110.
12. Centers for Disease Control and Prevention. (2003). Pediatric HIV/AIDS surveillance report and slides. Retrieved May 26, 2003, from http://www.cdc.gov/hiv/graphics/pediatri.htm
13. Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M. J., et al. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine, 331, 1173-1180.
14. Cozen, W., Mascola, L., Enguidanos, R., Bauch, S., Giles, M., Paxton, P. et al. (1993). Screening for HIV and Hepatitis B Virus in Los Angeles County Prenatal Clinics: A Demonstration Project. Journal of Acquired Immune Deficiency Syndrome, 6(1), 95-98.
15. Dabis, F., Msellati, P., Meda, N., Welffens-Ekra, C., You, B., Manigart, O. et al. (1999). Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet, 353, 786-792.
16. Davis, S.F., Rosen, D., Steinberg, S., Wortley, P.M., Karon, J., & Gwinn, M. (1998). Trends in HIV prevalence among childbearing women in the United States, 1989-1994. Journal of Acquired Immune Deficiency Syndrome Human Retrovir, 19, 158-164.
17. De Bruyn, M. & Paxton, S. (2005). HIV testing of pregnant women-what is needed to protect positive women's needs and rights? Sex Health, 2(3),143-51.
18. Ethier, K.A., Fox-Tierney, R., Nicholas, W.C., Salisbury, K.M., & Ickovics, J.R.. (2000). Organizational Predictors of Prenatal HIV Counseling and Testing. American Journal of Public Health, 90(9),1448-1451.
19. Guay, L.A., Musoke, P., Fleming, T., Bagenda, D. Allen, M., Nakabiito, C., et al. (1999). Intrapartuma dn neonatal single dose nevirapine compared with zidovudine refimens to prevent mother-to-child transmission of human immunodeficiency virus. Lancet, 354, 795-802.
20. Healton, C.H., Messeri, P., Abramson, S., Howard, J., Sorin, M.D., & Bayer. R. (1996). A Balancing act: The tension between case-finding and primary prevention strategies in New York State's voluntary HIV counseling and testing program in women's health care settings. American Journal of Preventive Medicine, 12(4 Supp),53-60.
21. Kropp, R.Y., Montgomery, E.T., Hill, D.W., Ruiz, J.D., & Maldonado, Y.A. (2005). Unique challenges to preventing perinatal HIV transmission among Hispanic women in California: Results of a needs assessment. AIDS Education and Prevention, 17(1), 22-40..
22. Lansky, A., Jones, J.L., Frey, R.L., & Lindegren, M, L. (2001). Trends in HIV testing among pregnant women: United States, 1994-1999. American Journal of Public Health, 91(8),1291-1294.
23. Lester, P., Partridge, J.C., Chesney, M.A., & Cooke, M. (1995). The consequence of a positive prenatal HIV antibody test for women. Journal of Aquired Immune Deficiency Syndromes and Human Retrovirology, 10, 341-349.
24. Lindegren, M.L., Steinberg, S., & Byers, R.H. (2000). Epidemiology of HIV/AIDS in Children. Pediatric Clinics of North America, 47(1), 1-20.
25. Lindsay, M.K., Adefris, W., Peterson, H.B., Williams, H., Johnson, J., & Klein, L. (1991). Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population. Obstetrics and Gynecology,78(4), 678-680.
26. Los Angeles County, Department of Health Services. Office of Public Health Communications (2001, February 4). Pattern of HIV-infection in newborns causes concern. (Press release).
27. Mofenson, L.M., & the Committee on Pediatric AIDS. (2000). Technical report: Perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics, 106(6). Retrieved November 5, 2001, from http://www.pediatrics.org/cgi/content/full/106/6/e88
28. Peters, V., Liu, K.L., Dominguez, K., Frederick, T., Melville, S., Hsu, H.W., et al. (2003). Missed opportunities for perinatal HIV Prevention among HIV-exposed infants born 1996-2000, Pediatric Spectrum of Disease Cohort. Pediatrics, 111, 1186-1191.
29. The Petra Study Team. (2002). Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra Study), A randomized double-blind placebo-controlled trial. The Lancet, 359,1178-1186.
30. RAND California (2002). Population and demographic statistics. Population in US states by race/ethnicity and age group. Retrieved November 6, 2002, from http://ca.rand.org/stats/popdemo/popraceageUS.html
31. Roome, A., Carley, K., Melchreit, R., Foye, G., & Hadler, J. (1999). Testing pregnant women for HIV: A survey of obstetricians and review of patient prenatal/ obstetric medical records - Connecticut 1996-1997. Connecticut Medicine, 63(9), 523-529.
32. Royce, R., Walter, E.B., Fernandez, .IM., Wilson, T.E,, Ickovics, J.R., Simonds, R,J. (2001). Barriers to universal prenatal HIV testing in 4 US locations in 1997. American Journal of Public Health, 91(5), 727-733.
33. Ruiz, J.D., Molitor, F., Prussing, E., Peck, L., & Grasso, P. (2002). Prenatal HIV counseling and testing in California: Women's experiences and providers' practices. AIDS Education and Prevention, 14(3), 190-195.
34. Schuman, P., Jones, T. B., Ohmit, S., Marburg, C., & Laken, M. P. (2004). Voluntary HIV counseling and testing of pregnant women - An assessment of compliance with Michigan public health statues. Medscope General Medicine, 6(2), 52.
35. Shaffer, N., Chuachoowong, R., Mock, P.A., Bhadrakom, C., Siriwasin, W., Young, N.L., et al. (1999). Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet, 353, 773-780.
36. Walter, E.B., Royce, R., Fernandez, I., Dehovitz, J., Ickovics, J.R., & Lampe, M.A. (2001). New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection. Obstetrics and Gynecology, 97(1):70-76.
37. Wiktor, S.Z., Ekpini, E., Karon, J., Nkengasong, J. Maurice, C. Severin, S.T., et al. (1999). Short course zidovudine for prevention of mother-to child transmission of HIV-1 in Abidjan, Cote d'Ivoire and Burkina Faso: A randomized trial. The Lancet, 353, 781-785.